Gilbertson M - Search Results

1

Recommendation for TP53 mutation testing in newly diagnosed mantle cell lymphoma: a statement from working groups sponsored by the Victorian Comprehensive Cancer Centre.

Tam CS, Gregory GP, Ku M, Fleming S, Handunnetti SM, Lee D, Walker P, Perkins A, Lew TE, Sirdesai S, Chua CC, Gilbertson M, Lasica M, Anderson MA, Renwick W, Grigg A, Patil S, Opat S, Friebe A, Cooke R, De Boer J, Spencer A, Ritchie D, Agarwal R, Blombery P. Tam CS, et al. Among authors: gilbertson m. Intern Med J. 2022 Jul;52(7):1286-1287. doi: 10.1111/imj.15851. Intern Med J. 2022. PMID: 35879233 No abstract available.

2

Excellent outcomes of transformed lymphomas in the rituximab era without autologous stem cell transplantation: an Australian single-centre experience.

Tedjaseputra A, Gilbertson M, Low M, Fedele PL, Kumar B, Simpson I, Grigoriadis G, Shortt J, Opat S, Gregory GP. Tedjaseputra A, et al. Among authors: gilbertson m. Intern Med J. 2021 Nov;51(11):1825-1834. doi: 10.1111/imj.14965. Epub 2021 Oct 24. Intern Med J. 2021. PMID: 32609419

3

High-dose therapy and autologous stem cell transplantation may only be applicable to selected patients with secondary CNS diffuse large B-cell lymphoma.

Cheah CY, Joske D, Cull G, Gilbertson M, Opat SS, Tam CS, Wirth A, Seymour JF. Cheah CY, et al. Among authors: gilbertson m. Br J Haematol. 2017 Sep;178(6):991-994. doi: 10.1111/bjh.14187. Epub 2016 Jul 29. Br J Haematol. 2017. PMID: 27470657 Free article. No abstract available.

4

A multicenter retrospective comparison of induction chemoimmunotherapy regimens on outcomes in transplant-eligible patients with previously untreated mantle cell lymphoma.

Ng ZY, Bishton M, Ritchie D, Campbell R, Gilbertson M, Hill K, Ratnasingam S, Schwarer A, Manos K, Shorten S, Ng M, Nelson N, Xin L, De Mel Widanalage S, Sunny T, Purtill D, Poon M, Johnston A, Cochrane T, Lee HP, Hapgood G, Tam C, Opat S, Hawkes E, Seymour J, Cheah CY. Ng ZY, et al. Among authors: gilbertson m. Hematol Oncol. 2019 Aug;37(3):253-260. doi: 10.1002/hon.2618. Epub 2019 May 24. Hematol Oncol. 2019. PMID: 30983008

5

Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm study.

Pasricha SR, Gilbertson M, Indran T, Bennett A, van Dam M, Coughlin E, Dev A, Chunilal S, Opat S. Pasricha SR, et al. Among authors: gilbertson m. Intern Med J. 2021 Aug;51(8):1304-1311. doi: 10.1111/imj.15195. Intern Med J. 2021. PMID: 33462917 Clinical Trial.

6

Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCL.

Miller JH, Gilbertson M, MacManus MP, Wirth A, Opat SS, Gregory GP. Miller JH, et al. Among authors: gilbertson m. Blood Adv. 2021 Dec 14;5(23):5112-5115. doi: 10.1182/bloodadvances.2021005061. Blood Adv. 2021. PMID: 34625795 Free PMC article. No abstract available.

7

Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma.

Fedele PL, Gregory GP, Gilbertson M, Shortt J, Kumar B, Opat S, Grigoriadis G. Fedele PL, et al. Among authors: gilbertson m. Ann Hematol. 2016 Mar;95(4):667-8. doi: 10.1007/s00277-016-2601-6. Epub 2016 Jan 23. Ann Hematol. 2016. PMID: 26801792 No abstract available.

8

Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma.

Ratnasingam S, Casan J, Shortt J, Hawkes E, Gilbertson M, McQuilten Z, Grigoriadis G, Htun KT, Htet SM, Campbell P, Chai KL, Quach H, Patil S, Opat S. Ratnasingam S, et al. Among authors: gilbertson m. Sci Rep. 2019 Sep 19;9(1):13544. doi: 10.1038/s41598-019-49776-9. Sci Rep. 2019. PMID: 31537857 Free PMC article.

9

Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy.

Yuen HLA, Slocombe A, Heron V, Chunilal S, Shortt J, Tatarczuch M, Grigoriadis G, Patil S, Gregory GP, Opat S, Gilbertson M. Yuen HLA, et al. Among authors: gilbertson m. Res Pract Thromb Haemost. 2020 Jul 23;4(6):997-1003. doi: 10.1002/rth2.12415. eCollection 2020 Aug. Res Pract Thromb Haemost. 2020. PMID: 32864550 Free PMC article.

10

Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma.

Chee A, Low MS, Vilcassim S, Gregory GP, Gilbertson M, Ratnasingam S, Grigoriadis G, Fedele PL. Chee A, et al. Among authors: gilbertson m. Br J Haematol. 2018 Sep;182(5):739-741. doi: 10.1111/bjh.14871. Epub 2017 Aug 31. Br J Haematol. 2018. PMID: 28857117 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

153 results

Search Page